Th2 cells also release IL-4 and IL-10, anti-inflammatory interleukins which suppress the immune system’s ability to fight cancer, since inflammation allows for the signaling of macrophages and CD8+ T cells to fight infections or the causes of cellular damage. The gene discussed is CD8A; the disease is cancer.